Comment

Comment - Soft Drinks & Water - Ribena and Lucozade: Cash In, or Invest?

Most popular

What will be Pernod Ricard's priorities?

Pernod Ricard Performance Trends 2014-2018 - data

What are Diageo's priorities for the years ahead?

The biggest global risks facing drinks co's in '19

MORE

Earlier this month, UK pharmaceutical and "consumer healthcare" conglomerate GSK took a look at its Lucozade and Ribena brands, and set itself a choice: Does it sell the two, or does it look at setting up an investment programme? Richard Corbett considers the firm's dilemma.


Related Content

What's coming up in soft drinks in 2018? - Predictions for the Year Ahead - Comment

What's coming up in soft drinks in 2018? - Predictions for the Year Ahead - Comment...

How the sugar tax has transformed the soft drinks category - Comment

How the sugar tax has transformed the soft drinks category - Comment...

Why Deposit Return Schemes are the ultimate option for soft drinks - Comment

Why Deposit Return Schemes are the ultimate option for soft drinks - Comment ...

How soft drinks can milk (or not) the vegan trend - Comment

How soft drinks can milk (or not) the vegan trend - Comment...

Oops! This article is copy protected.

Why can’t I copy the text on this page?

The ability to copy articles is specially reserved for people who are part of a group membership.

How do I become a group member?

To find out how you and your team can copy and share articles and save money as part of a group membership call Sean Clinton on
+44 (0)1527 573 736 or complete this form..



Forgot your password?